Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000668593 | SCV000793221 | uncertain significance | Deficiency of hydroxymethylglutaryl-CoA lyase | 2017-08-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000668593 | SCV002136928 | uncertain significance | Deficiency of hydroxymethylglutaryl-CoA lyase | 2021-09-17 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with glutamic acid at codon 203 of the HMGCL protein (p.Gly203Glu). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and glutamic acid. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with 3HMG-CoA lyase deficiency (PMID: 16601870). ClinVar contains an entry for this variant (Variation ID: 553197). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Experimental studies have shown that this variant affects HMGCL protein function (PMID: 16601870). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV000668593 | SCV004172545 | uncertain significance | Deficiency of hydroxymethylglutaryl-CoA lyase | 2023-04-11 | criteria provided, single submitter | clinical testing |